Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 45,328 | 146,930 | 97,551 | 61,122 | 26,904 |
| Depreciation Amortization | 1,994 | 8,670 | 6,463 | 4,306 | 2,123 |
| Income taxes - deferred | 3,292 | 11,020 | 9,848 | 5,045 | 3,425 |
| Accounts receivable | 22,567 | -108,430 | -87,674 | -59,726 | -49,413 |
| Accounts payable and accrued liabilities | -1,233 | 2,330 | 4,533 | 9,409 | 142 |
| Other Working Capital | 9,244 | -139,595 | -117,075 | -79,755 | -56,751 |
| Other Operating Activity | -22,943 | 129,471 | 101,111 | 61,063 | 53,895 |
| Operating Cash Flow | $58,249 | $50,396 | $14,757 | $1,464 | $-19,675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,457 | -22,575 | -21,491 | -7,123 | -4,701 |
| Purchase Sale Intangibles | -53 | -316 | -124 | -124 | -19 |
| Other Investing Activity | -53 | 684 | -124 | -124 | -19 |
| Investing Cash Flow | $2,404 | $-21,891 | $-21,615 | $-7,247 | $-4,720 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 125,000 | 105,000 | 72,500 | 30,000 | N/A |
| Debt Repayment | -469 | -108,282 | -74,282 | -30,375 | N/A |
| Common Stock Issued | 588 | 2,984 | 2,554 | 2,165 | 101 |
| Common Stock Repurchased | -130,191 | -31,940 | -23,038 | N/A | 0 |
| Other Financing Activity | -5,058 | -11,784 | -12,638 | -8,869 | -7,228 |
| Financing Cash Flow | $-10,130 | $-44,022 | $-34,904 | $-7,079 | $-7,127 |
| Beginning Cash Position | 87,630 | 103,147 | 103,147 | 103,147 | 103,147 |
| End Cash Position | 138,153 | 87,630 | 61,385 | 90,285 | 71,625 |
| Net Cash Flow | $50,523 | $-15,517 | $-41,762 | $-12,862 | $-31,522 |
| Free Cash Flow | |||||
| Operating Cash Flow | 58,249 | 50,396 | 14,757 | 1,464 | -19,675 |
| Capital Expenditure | -2,543 | -22,575 | -21,491 | -7,123 | -4,701 |
| Free Cash Flow | 55,706 | 27,821 | -6,734 | -5,659 | -24,376 |